SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,375,000 | -30.3% | 232,466 | +0.4% | 0.00% | -33.3% |
Q2 2023 | $4,844,000 | +27.4% | 231,443 | +28.6% | 0.01% | +20.0% |
Q1 2023 | $3,802,000 | -17.0% | 180,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $4,581,000 | +5.3% | 180,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $4,349,000 | +24.9% | 180,000 | -0.5% | 0.01% | +25.0% |
Q2 2022 | $3,482,000 | +10.7% | 180,991 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $3,145,000 | -20.6% | 180,991 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $3,962,000 | +14.5% | 180,991 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $3,459,000 | +11.3% | 180,991 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $3,108,000 | -23.2% | 180,991 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $4,047,000 | +1.1% | 180,991 | +0.6% | 0.01% | 0.0% |
Q4 2020 | $4,003,000 | +50.7% | 180,000 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $2,657,000 | -0.4% | 180,000 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $2,668,000 | +35.1% | 180,000 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $1,975,000 | +25.0% | 180,000 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $1,580,000 | +17.5% | 180,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $1,345,000 | -73.2% | 180,000 | -66.7% | 0.00% | -33.3% |
Q2 2019 | $5,028,000 | +432.1% | 540,000 | +200.0% | 0.00% | +50.0% |
Q1 2019 | $945,000 | +18.0% | 180,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $801,000 | -44.9% | 180,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $1,454,000 | +15.0% | 180,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,264,000 | +11390.9% | 180,000 | +14900.0% | 0.00% | – |
Q4 2017 | $11,000 | – | 1,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |